IHL 0.00% 4.1¢ incannex healthcare limited

Ann: IHL-42X positive phase 2 clinical trial results, page-116

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 3 Posts.
    lightbulb Created with Sketch. 2
    Very positive results for a proof of concept study IMO! Keen to see analysis by dose when full CSR is available and excited by potential for even greater benefits with a longer treatment duration (beyond 7 days as in this study) in subsequent larger phase 2 trial
 
watchlist Created with Sketch. Add IHL (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.